Lmr Partners LLP Biomarin Pharmaceutical Inc Transaction History

Lmr Partners LLP

$8.3 Billion
Q1 2025

A detailed history of Lmr Partners LLP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Lmr Partners LLP holds 9,800 shares of BMRN stock, worth $569,772. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,800

Previous 9,800 -0.0%

Holding current value

$569,772

Previous $644,000 7.45%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$61.93 - $70.49 $4.38 Million - $4.99 Million	-70,730 Reduced 94.12%	4,418 $290,000
Q3 2024 Nov 07, 2024	SELL	$69.02 - $93.84 $3.31 Million - $4.5 Million	-47,969 Reduced 38.96%	75,148 $5.28 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $3.34 Million - $4.14 Million	44,917 Added 57.44%	123,117 $10.1 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $139,863 - $180,765	1,835 Added 2.4%	78,200 $7.54 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $3.52 Million - $3.91 Million	41,354 Added 118.12%	76,365 $6.76 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $3.42 Million - $3.95 Million	-39,408 Reduced 52.95%	35,011 $3.03 Million
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $1.53 Million - $2.05 Million	17,494 Added 30.73%	74,419 $7.24 Million
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $165,097 - $221,605	2,040 Added 3.72%	56,925 $5.89 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $1.56 Million - $1.84 Million	18,932 Added 52.66%	54,885 $4.65 Million
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $3.91 Million - $4.75 Million	-54,650 Reduced 60.32%	35,953 $2.98 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $4.12 Million - $5.14 Million	55,448 Added 157.72%	90,603 $6.99 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $2.52 Million - $3.22 Million	35,155 New	35,155 $3.11 Million
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $590,309 - $674,785	-7,895 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $1.54 Million - $1.87 Million	-20,605 Reduced 72.3%	7,895 $596,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $2.07 Million - $2.57 Million	28,500 New	28,500 $2.5 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $514,159 - $690,960	-8,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $539,200 - $680,880	8,000 New	8,000 $539,000

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

185M

Call Options Held

1.25M

Put Options Held

992K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Account